Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP450028.RAKr4rxQpwL9nolJDLqGW4SqBS3ESLWrz4dUE5_ODY6wI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP450028.RAKr4rxQpwL9nolJDLqGW4SqBS3ESLWrz4dUE5_ODY6wI130_assertion type Assertion NP450028.RAKr4rxQpwL9nolJDLqGW4SqBS3ESLWrz4dUE5_ODY6wI130_head.
- NP450028.RAKr4rxQpwL9nolJDLqGW4SqBS3ESLWrz4dUE5_ODY6wI130_assertion description "[In an attempt to elucidate the relationship between biomarkers of tumor hypoxia, glycolysis and angiogenesis, we tested the hypothesis that intratumoral gene expression of the hypoxia response (hypoxia inducible factor [HIF1 alpha and 2 alpha]), glycolysis (lactate dehydrogenase A [LDHA]), glucose metabolism (glucose transporter-1 [Glut-1]) and genes involved in angiogenesis (i.e., VEGFA, VEGFR1-3, and neuropilin [NRP]1) are upregulated in metastatic colorectal cancer (mCRC) patients with high serum lactate dehydrogenase (LDH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450028.RAKr4rxQpwL9nolJDLqGW4SqBS3ESLWrz4dUE5_ODY6wI130_provenance.
- NP450028.RAKr4rxQpwL9nolJDLqGW4SqBS3ESLWrz4dUE5_ODY6wI130_assertion evidence source_evidence_literature NP450028.RAKr4rxQpwL9nolJDLqGW4SqBS3ESLWrz4dUE5_ODY6wI130_provenance.
- NP450028.RAKr4rxQpwL9nolJDLqGW4SqBS3ESLWrz4dUE5_ODY6wI130_assertion SIO_000772 18086000 NP450028.RAKr4rxQpwL9nolJDLqGW4SqBS3ESLWrz4dUE5_ODY6wI130_provenance.
- NP450028.RAKr4rxQpwL9nolJDLqGW4SqBS3ESLWrz4dUE5_ODY6wI130_assertion wasDerivedFrom befree-20150227 NP450028.RAKr4rxQpwL9nolJDLqGW4SqBS3ESLWrz4dUE5_ODY6wI130_provenance.
- NP450028.RAKr4rxQpwL9nolJDLqGW4SqBS3ESLWrz4dUE5_ODY6wI130_assertion wasGeneratedBy ECO_0000203 NP450028.RAKr4rxQpwL9nolJDLqGW4SqBS3ESLWrz4dUE5_ODY6wI130_provenance.